Ippei Sakamaki

1.1k total citations
48 papers, 746 citations indexed

About

Ippei Sakamaki is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Ippei Sakamaki has authored 48 papers receiving a total of 746 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 11 papers in Epidemiology and 10 papers in Immunology. Recurrent topics in Ippei Sakamaki's work include SARS-CoV-2 and COVID-19 Research (11 papers), COVID-19 Clinical Research Studies (11 papers) and Immunotherapy and Immune Responses (7 papers). Ippei Sakamaki is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (11 papers), COVID-19 Clinical Research Studies (11 papers) and Immunotherapy and Immune Responses (7 papers). Ippei Sakamaki collaborates with scholars based in Japan, United States and Vietnam. Ippei Sakamaki's co-authors include Hong Qin, Larry W. Kwak, Yoshihiro Yamamoto, Hitoshi Kawasuji, Akitoshi Ueno, Yuki Miyajima, Qing Yi, Guo‐Wei Wei, Karen C. Dwyer and Yared Hailemichael and has published in prestigious journals such as Nature Medicine, Blood and PLoS ONE.

In The Last Decade

Ippei Sakamaki

42 papers receiving 739 citations

Peers

Countries citing papers authored by Ippei Sakamaki

Since Specialization

Citations

This map shows the geographic impact of Ippei Sakamaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ippei Sakamaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ippei Sakamaki more than expected).

Fields of papers citing papers by Ippei Sakamaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ippei Sakamaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ippei Sakamaki. The network helps show where Ippei Sakamaki may publish in the future.

Co-authorship network of co-authors of Ippei Sakamaki

This figure shows the co-authorship network connecting the top 25 collaborators of Ippei Sakamaki. A scholar is included among the top collaborators of Ippei Sakamaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ippei Sakamaki. Ippei Sakamaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Infection rate among close contacts of patients with coronavirus disease in Japan: a descriptive study and literature review 2023 ·Asian Biomedicine ·Osamu Yamamura, (unknown), Ippei Sakamaki, (unknown), (unknown), Hiromichi Iwasaki	0
2	Antibody level dynamics until after the third dose of COVID-19 vaccination 2023 ·Heliyon ·(unknown), Ippei Sakamaki, (unknown), Kunio Torii, Norikazu Hashimoto, Hiromichi Iwasaki, Masayuki Iwano, Hideki Kimura	0
3	Characteristics and Outcomes of Patients Infected With Conventional Strains and the Alpha Variant of Severe Acute Respiratory Syndrome Coronavirus 2 2023 ·Infectious Diseases in Clinical Practice ·(unknown), Osamu Yamamura, Ippei Sakamaki, (unknown), (unknown), Hiromichi Iwasaki	0
4	Appropriateness of surgical antimicrobial prophylaxis in Japanese university hospitals 2022 ·Journal of Hospital Infection ·Hiroshi Morioka, Hiroki Ohge, Miki Nagao, Hideo Kato, (unknown), Kentaro Yamada, Tsuyoshi Yamada, Nobuyuki Shimono, Yoko Nukui, Sei‐ichi Yoshihara, Ippei Sakamaki, Kisato Nosaka, Yoko Kubo, Hideki Kawamura, Yuji Fujikura, (unknown), Mitsuhiro Sunakawa, Tetsuya Yagi	6
5	Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein 2021 ·Virology Journal ·Hideki Tani, Miyuki Kimura, Long Tan, Yoshihiro Yoshida, Tatsuhiko Ozawa, Hiroyuki Kishi, Shuetsu Fukushi, Masayuki Saijo, Kaori Sano, Tadaki Suzuki, Hitoshi Kawasuji, Akitoshi Ueno, Yuki Miyajima, Yasutaka Fukui, Ippei Sakamaki, Yoshihiro Yamamoto, Yoshitomo Morinaga	37
6	Delayed neutralizing antibody response in the acute phase correlates with severe progression of COVID-19 2021 ·Scientific Reports ·Hitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani, Miyuki Kimura, Hiroshi Yamada, Yoshihiro Yoshida, (unknown), Makito Kaneda, (unknown), (unknown), Akitoshi Ueno, Yuki Miyajima, (unknown), Yasutaka Fukui, Ippei Sakamaki, Yoshihiro Yamamoto	8
7	Sitafloxacin reduces tumor necrosis factor alpha (TNFα) converting enzyme (TACE) phosphorylation and activity to inhibit TNFα release from lipopolysaccharide-stimulated THP-1 cells 2021 ·Scientific Reports ·Ippei Sakamaki, (unknown), Wakana Ohashi, Yukië Tanaka, (unknown), Kei Tomihara, Yoshihiro Yamamoto, Hiromichi Iwasaki	1
8	Prolonged viral clearance of severe acute respiratory syndrome coronavirus 2 in the older aged population 2021 ·Journal of Infection and Chemotherapy ·Akitoshi Ueno, Hitoshi Kawasuji, Yuki Miyajima, Yasutaka Fukui, Ippei Sakamaki, Mayuko Saito, (unknown), Yoshitomo Morinaga, Kazunori Oishi, Yoshihiro Yamamoto	5
9	Proposal of initial and maintenance dosing regimens with linezolid for renal impairment patients 2021 ·BMC Pharmacology and Toxicology ·Hitoshi Kawasuji, Yasuhiro Tsuji, Chika Ogami, (unknown), Akitoshi Ueno, Yuki Miyajima, (unknown), Ippei Sakamaki, Yoshihiro Yamamoto	29
10	Transmissibility of COVID-19 depends on the viral load around onset in adult and symptomatic patients 2020 ·PLoS ONE ·Hitoshi Kawasuji, (unknown), Makito Kaneda, Akitoshi Ueno, Yuki Miyajima, (unknown), Yasutaka Fukui, Yoshihiro Yoshida, Miyuki Kimura, Hiroshi Yamada, Ippei Sakamaki, Hideki Tani, Yoshitomo Morinaga, Yoshihiro Yamamoto	93
11	Rapid Identification of Candida Species in Candidemia Directly from Blood Samples Using Imperfect Match Probes 2020 ·Scientific Reports ·(unknown), Hideki Niimi, Ippei Sakamaki, Yoshihiro Yamamoto, Isao Kitajima	4
12	Congenital tuberculosis in an extremely preterm infant and prevention of nosocomial infection 2019 ·Journal of Infection and Chemotherapy ·Kentaro Tamura, Hitoshi Kawasuji, (unknown), (unknown), (unknown), (unknown), Ippei Sakamaki, Yoshihiro Yamamoto, (unknown), Junko Isobe, Satoshi Mitarai, Noriko Yoneda, Satoshi Yoneda, Shigeru Saito, Taketoshi Yoshida	7
13	Bacteremia caused by Slackia exigua: A report of two cases and literature review 2019 ·Journal of Infection and Chemotherapy ·Hitoshi Kawasuji, Hiroyasu Kaya, (unknown), Akitoshi Ueno, Yuki Miyajima, Takeshi Tsuda, Hirokazu Taniguchi, Masahiko Nakamura, Akinori Wada, Ippei Sakamaki, Hideki Niimi, Yoshihiro Yamamoto	8
14	Novel BAFF-Receptor Antibody to Natively Folded Recombinant Protein Eliminates Drug-Resistant Human B-cell Malignancies In Vivo 2017 ·Clinical Cancer Research ·Hong Qin, Guo‐Wei Wei, Ippei Sakamaki, Zhenyuan Dong, Wesley A. Cheng, D. Lynne Smith, Feng Wen, Han Sun, Kunhwa Kim, (unknown), Laura Bover, Sattva S. Neelapu, Larry W. Kwak	24
15	Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice 2014 ·Nature Medicine ·Hong Qin, (unknown), Ippei Sakamaki, Guo‐Wei Wei, (unknown), Sheetal Rao, Jianfei Qian, Yared Hailemichael, Roza Nurieva, Karen C. Dwyer, Johannes Roth, Qing Yi, Willem W. Overwijk, Larry W. Kwak	189
16	Safety of Intradermal Injection of Monosodium Urate Crystals as a Vaccine Carrier in Volunteers 2011 ·Nucleosides Nucleotides & Nucleic Acids ·Ippei Sakamaki, Kunihiro Inai, Hiroshi Tsutani	4
17	Translational development of vaccination strategies in follicular NHL 2011 ·Best Practice & Research Clinical Haematology ·Ippei Sakamaki, Hong Qin, Larry W. Kwak	4
18	HIGH-DOSE MELPHALAN WITH AUTOLOGOUS STEM CELL TRANSPLANTATION FOR THE TREATMENT OF AMYLOID LIGHT-CHAIN AMYLOIDOSIS 2008 ·Japanese Journal of Transfusion and Cell Therapy ·Yasukazu Kawai, Ippei Sakamaki, (unknown), (unknown), (unknown), (unknown), Naoko Hosono, Shinji Kishi, Takahiro Yamauchi, Yoshimasa Urasaki, Akira Yoshida, Hiromichi Iwasaki, Hiroshi Tsutani, Takanori Ueda	0
19	Binding of monosodium urate crystals with idiotype protein efficiently promote dendritic cells to induce cytotoxic T cells 2008 ·Cancer Science ·Ippei Sakamaki, Kunihiro Inai, (unknown), Takanori Ueda, Hiroshi Tsutani	7
20	Successful Treatment of a 74-year-old man with Refractory Anemia with Excess of Blasts in Transformation(RAEB in T) by Low-Dose Ara-C Injection. 1995 ·Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics ·(unknown), (unknown), Ippei Sakamaki, (unknown), (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact